Schmidt

Marjanka Schmidt

Group leader

Phone

Email

Marjanka Schmidt

Marjanka Schmidt is an epidemiologist with expertise in genetics of breast cancer. She leads a research group at the Netherlands Cancer Institute and has a chair at Leiden University Medical Center. Her research line focuses on the effects of genetic variants on risk of breast cancer subtypes, prognosis and long-term outcome of breast cancer, combining the areas of epidemiological and molecular research. One major promise is that advances in the genetics area will lead to personalized medicine, where preventive and therapeutic interventions for complex diseases can be individually tailored to a person's genetic profile. Marjanka's group aims to contribute to the genome-based applications in health care practice by elucidating the role of germline variants in breast cancer risk and prognosis by molecular and genetic epidemiological studies, as well as addressing ethical, legal and societal aspects of genomics.

Work experience

2019 - present
Senior group Leader at the Division of Molecular Pathology and the Division of Psychosocial Research and Epidemiology, NKI-AVL; professor of genetic epidemiology of (breast) cancer at the Department of Clinical Genetics, Leiden University Medical Centre

2015 - 2019
Group Leader/Associate Professor at the Division of Molecular Pathology and the Division of Psychosocial Research and Epidemiology, NKI-AVL

2010 - 2015
Junior Group Leader/Assistant Professor (tenure track) at the Division of Molecular Pathology and the Division of Psychosocial Research and Epidemiology,
NKI-AVL. Funded by a Personal Translational Cancer Research Award of the Dutch Cancer Society

2008 - 2010
European Union 7th Framework funded COST-STSM-BM0606 Fellowships. Multiple working visits to University of Cambridge, Strangeways Research Laboratory, UK, and Helsinki University Central Hospital, Finland

2007 - 2010 
Project coordinator and epidemiological researcher in a senior postdoc position, affiliated with the Divisions of Psychosocial Research and Epidemiology; Experimental Therapy; and Pathology, NKI-AVL

 

Additional activities

  • Professor of Genetic epidemiology of (breast) cancer, Leiden University Medical Centre
  • Lead of the Early Detection theme NKI-AVL
  • Lead of ‘ELSI and data sharing’ of Digital Oncology project NKI-AVL
  • Fellow of the European Academy of Cancer Sciences
  • Co-chair of the Pathology and Survival Working Group in the Breast Cancer Association Consortium (BCAC)
  • Member of BCAC Data Access Coordination Committee
  • Member of the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
  • Coordinator Netherlands Collaborative Group on Hereditary Breast cancer (HEBON)
  • Coordinator International BRCA1/2 Carrier Cohort Study (IBCCS)
  • Member of the EORTC Breast Group
  • Secretary of the Dutch Society Committee on Regulation of Research (COREON)
  • Member of the ELSI community of Health-RI
  • Member of the Dutch Epidemiology Society (VvE)
  • Scientific Advisory Board member and chair of UNICANCER, France
  • Scientific Advisory Board chair of the MyPeBS EU Horizon 2020 study, France
  • Associated Editor, European Journal of Cancer

Explore the research of the Marjanka Shmidt group

Marjanka Schmidt

Learn more about our...

Facilities & platforms
Research groups
Vacancies
Disclaimer
Privacy statement
Cookies
Change cookie settings